News — TAMPA, Fla. (Oct. 10, 2017) – , Ph.D., director of ’s , delivered the opening keynote address at the 2017 (EUROGIN) International Multidisciplinary Congress. The focus of this year’s conference is human papillomavirus (HPV) and its associated cancers.
Nearly 2 million cancer cases a year are caused by infection, such as HPV. Giuliano, who specializes in researching this link, will tackle the question, “Is the elimination of HPV infection and related diseases possible?”
“There have been major advancements in HPV research. We have vaccines that can prevent HPV-related cancers, but they are not widely used,” said Giuliano. “We want to bring the scientific and medical communities together to get more boys and girls vaccinated worldwide.”
As one of the world’s leading HPV experts, Giuliano has led studies of cervical and penile cancer nationally and internationally, including the multinational HPV Infection in Men study. In 2014, she spearheaded research that led to the FDA approving Gardasil 9, a vaccine to protect against nine types of HPV. The impact? The potential to eliminate cervical cancer.
The opening address took place Sunday, Oct. 8, at the EUROGIN Conference in Amsterdam. For more information on the conference, please visit .
About Moffitt Cancer Center Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 , a distinction that recognizes Moffitt’s excellence in research, clinical trials, prevention and cancer control. Moffitt is listed as one of the top 10 cancer hospitals in the nation and has been listed in as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 5,700 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit , and follow the momentum on , and .
###
RSS